Trial Profile
A Multinational Observational Study to Evaluate the Safety of Repatha® in Pregnancy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2020
Price :
$35
*
At a glance
- Drugs Evolocumab (Primary)
- Indications Hyperlipoproteinaemia type IIa
- Focus Adverse reactions
- Sponsors Amgen
- 10 Nov 2020 Status changed from recruiting to discontinued.
- 26 Jan 2017 Status changed from not yet recruiting to recruiting.
- 28 Sep 2016 New trial record